Logo image of JKS

JINKOSOLAR HOLDING CO-ADR (JKS) Stock Fundamental Analysis

USA - NYSE:JKS - US47759T1007 - ADR

24.1 USD
-1.29 (-5.08%)
Last: 9/26/2025, 8:04:47 PM
24.2 USD
+0.1 (+0.41%)
After Hours: 9/26/2025, 8:04:47 PM
Fundamental Rating

3

Taking everything into account, JKS scores 3 out of 10 in our fundamental rating. JKS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. JKS may be in some trouble as it scores bad on both profitability and health. JKS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

JKS had positive earnings in the past year.
In the past 5 years JKS has always been profitable.
Of the past 5 years JKS 4 years had a positive operating cash flow.
JKS Yearly Net Income VS EBIT VS OCF VS FCFJKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

The Return On Assets of JKS (-1.53%) is comparable to the rest of the industry.
JKS's Return On Equity of -10.18% is on the low side compared to the rest of the industry. JKS is outperformed by 66.96% of its industry peers.
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROIC N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
JKS Yearly ROA, ROE, ROICJKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

In the last couple of years the Profit Margin of JKS has declined.
JKS has a Gross Margin of 8.39%. This is amonst the worse of the industry: JKS underperforms 89.29% of its industry peers.
JKS's Gross Margin has declined in the last couple of years.
JKS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
JKS Yearly Profit, Operating, Gross MarginsJKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

JKS does not have a ROIC to compare to the WACC, probably because it is not profitable.
JKS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, JKS has more shares outstanding
Compared to 1 year ago, JKS has a worse debt to assets ratio.
JKS Yearly Shares OutstandingJKS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
JKS Yearly Total Debt VS Total AssetsJKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

A Debt/Equity ratio of 1.80 is on the high side and indicates that JKS has dependencies on debt financing.
JKS has a worse Debt to Equity ratio (1.80) than 93.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC2.39%
JKS Yearly LT Debt VS Equity VS FCFJKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

JKS has a Current Ratio of 1.33. This is a normal value and indicates that JKS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.33, JKS is doing worse than 86.61% of the companies in the same industry.
JKS has a Quick Ratio of 1.07. This is a normal value and indicates that JKS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.07, JKS is not doing good in the industry: 86.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.07
JKS Yearly Current Assets VS Current LiabilitesJKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

5

3. Growth

3.1 Past

The earnings per share for JKS have decreased strongly by -99.77% in the last year.
The Earnings Per Share has been decreasing by -2.87% on average over the past years.
JKS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.85%.
Measured over the past years, JKS shows a very strong growth in Revenue. The Revenue has been growing by 25.40% on average per year.
EPS 1Y (TTM)-99.77%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-464.91%
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%-40.23%

3.2 Future

JKS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.24% yearly.
The Revenue is expected to grow by 5.54% on average over the next years.
EPS Next Y-339.75%
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
EPS Next 5YN/A
Revenue Next Year-24.38%
Revenue Next 2Y-0.39%
Revenue Next 3Y5.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JKS Yearly Revenue VS EstimatesJKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B 100B
JKS Yearly EPS VS EstimatesJKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10

3

4. Valuation

4.1 Price/Earnings Ratio

JKS is valuated quite expensively with a Price/Earnings ratio of 1205.00.
Compared to the rest of the industry, the Price/Earnings ratio of JKS indicates a slightly more expensive valuation: JKS is more expensive than 61.61% of the companies listed in the same industry.
JKS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.32.
Based on the Price/Forward Earnings ratio of 17.25, the valuation of JKS can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JKS indicates a rather cheap valuation: JKS is cheaper than 83.93% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, JKS is valued a bit cheaper.
Industry RankSector Rank
PE 1205
Fwd PE 17.25
JKS Price Earnings VS Forward Price EarningsJKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800 1K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JKS is valued a bit cheaper than 76.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.79
JKS Per share dataJKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

A more expensive valuation may be justified as JKS's earnings are expected to grow with 41.24% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-27.67%
EPS Next 3Y41.24%

5

5. Dividend

5.1 Amount

JKS has a Yearly Dividend Yield of 10.82%, which is a nice return.
Compared to an average industry Dividend Yield of 2.23, JKS pays a better dividend. On top of this JKS pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, JKS pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.82%

5.2 History

JKS has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
JKS Yearly Dividends per shareJKS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.5 1

5.3 Sustainability

DPN/A
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
JKS Yearly Income VS Free CF VS DividendJKS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (9/26/2025, 8:04:47 PM)

After market: 24.2 +0.1 (+0.41%)

24.1

-1.29 (-5.08%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-28 2025-08-28/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners30.64%
Inst Owner Change-0.61%
Ins Owners4.9%
Ins Owner ChangeN/A
Market Cap1.24B
Analysts50.77
Price Target24.79 (2.86%)
Short Float %35.38%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield 10.82%
Yearly Dividend1.48
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-Date07-02 2025-07-02 (1.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)146.1%
Min EPS beat(2)-49.23%
Max EPS beat(2)341.42%
EPS beat(4)3
Avg EPS beat(4)228.1%
Min EPS beat(4)-49.23%
Max EPS beat(4)488.11%
EPS beat(8)6
Avg EPS beat(8)159.23%
EPS beat(12)8
Avg EPS beat(12)116.31%
EPS beat(16)10
Avg EPS beat(16)129.53%
Revenue beat(2)0
Avg Revenue beat(2)-86.88%
Min Revenue beat(2)-87.83%
Max Revenue beat(2)-85.94%
Revenue beat(4)0
Avg Revenue beat(4)-86.71%
Min Revenue beat(4)-88.24%
Max Revenue beat(4)-84.83%
Revenue beat(8)0
Avg Revenue beat(8)-86.12%
Revenue beat(12)3
Avg Revenue beat(12)-54.49%
Revenue beat(16)4
Avg Revenue beat(16)-42.2%
PT rev (1m)0%
PT rev (3m)1.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.74%
Valuation
Industry RankSector Rank
PE 1205
Fwd PE 17.25
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB 0.55
EV/EBITDA 16.79
EPS(TTM)0.02
EY0.08%
EPS(NY)1.4
Fwd EY5.8%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS225.71
BVpS50.01
TBVpS43.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.53%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.39%
FCFM N/A
ROA(3y)1.06%
ROA(5y)0.92%
ROE(3y)7.15%
ROE(5y)6.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-67.68%
PM growth 5Y-54.4%
GM growth 3Y-12.56%
GM growth 5Y-9.8%
F-ScoreN/A
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF N/A
Debt/EBITDA 10.8
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.07
Altman-Z N/A
F-ScoreN/A
WACC2.39%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.77%
EPS 3Y13.84%
EPS 5Y-2.87%
EPS Q2Q%-464.91%
EPS Next Y-339.75%
EPS Next 2Y-27.67%
EPS Next 3Y41.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.85%
Revenue growth 3Y31.23%
Revenue growth 5Y25.4%
Sales Q2Q%-40.23%
Revenue Next Year-24.38%
Revenue Next 2Y-0.39%
Revenue Next 3Y5.54%
Revenue Next 5YN/A
EBIT growth 1Y-189.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year204.26%
EBIT Next 3Y124.49%
EBIT Next 5YN/A
FCF growth 1Y-45.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.87%
OCF growth 3Y239.49%
OCF growth 5Y64.22%